Catalyst Wire Dossier Catalyst Wire Dossier

MK-0677

ibutamoren
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0677, covering 2018-05-14 to 2018-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects [Phase 2]

See pricing